CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,355,923 | -19.1% | 51,904 | 0.0% | 0.01% | -20.0% |
| Q2 2023 | $2,913,891 | +24.1% | 51,904 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $2,347,618 | +11.3% | 51,904 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $2,109,898 | -33.4% | 51,904 | +7.0% | 0.01% | -38.5% |
| Q3 2022 | $3,170,000 | +7.5% | 48,513 | 0.0% | 0.01% | +18.2% |
| Q2 2022 | $2,948,000 | +3.4% | 48,513 | +6.8% | 0.01% | +22.2% |
| Q1 2022 | $2,850,000 | -3.9% | 45,404 | +16.0% | 0.01% | 0.0% |
| Q4 2021 | $2,966,000 | -31.2% | 39,141 | +1.7% | 0.01% | -30.8% |
| Q3 2021 | $4,308,000 | -30.9% | 38,489 | -0.1% | 0.01% | -35.0% |
| Q2 2021 | $6,238,000 | +39.9% | 38,534 | +5.3% | 0.02% | +25.0% |
| Q1 2021 | $4,460,000 | -14.7% | 36,606 | +7.1% | 0.02% | -11.1% |
| Q4 2020 | $5,231,000 | +69.2% | 34,164 | -7.6% | 0.02% | +50.0% |
| Q3 2020 | $3,092,000 | +35.7% | 36,963 | +19.2% | 0.01% | +20.0% |
| Q2 2020 | $2,278,000 | +34.5% | 31,004 | -22.4% | 0.01% | +25.0% |
| Q1 2020 | $1,694,000 | -30.4% | 39,953 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $2,433,000 | – | 39,953 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |